17283-14-6

Usage

Uses

Used in Dietary Supplements and Bodybuilding Aids:
3,4-DIMETHYLPHENETHYLAMINE is used as a performance-enhancing substance for its potential to increase energy, focus, and athletic performance. It is often included in pre-workout supplements and weight loss products to support users in achieving their fitness goals.
Used in Pre-Workout Supplements:
In the sports nutrition industry, 3,4-DIMETHYLPHENETHYLAMINE is used as an ingredient in pre-workout supplements to provide users with a boost in energy and focus during their workouts. Its stimulant properties are believed to help improve physical performance and endurance.
Used in Weight Loss Products:
3,4-DIMETHYLPHENETHYLAMINE is also used in weight loss products due to its potential to increase energy levels and promote fat burning. Its inclusion in these products aims to assist users in achieving their weight management objectives by enhancing metabolism and supporting a higher level of physical activity.
However, it is important to note that there is limited scientific research on the efficacy and safety of 3,4-DIMETHYLPHENETHYLAMINE, and it has been banned as a dietary ingredient in the U.S. by the Food and Drug Administration due to concerns about potential health risks and lack of evidence supporting its safety and effectiveness. Users should exercise caution and consult with healthcare professionals before incorporating 3,4-DIMETHYLPHENETHYLAMINE into their dietary or fitness regimens.

InChI:InChI=1/C10H15N/c1-8-3-4-10(5-6-11)7-9(8)2/h3-4,7H,5-6,11H2,1-2H3

Upstream product

• 3020-06-2 3,4-dimethylphenylacetonitrile 
• 60-29-7 diethyl ether 
• 102-46-5 4-(chloromethyl)-1,2-dimethylbenzene 
• 17283-16-8 3,4-dimethylphenylacetic acid 
• 95-47-6 o-xylene 
• 17283-17-9 (3,4-dimethyl-phenyl)-acetic acid amide 

Downstream Products

• 1060788-35-3 (S)-1-(4-methanesulfonamidophenoxy)-3-(3,4-dimethylphenylethylamino)-2-propanol 
• 1443828-07-6 1-((4-methoxyphenoxy)methyl)-6,7-dimethyl-1,2,3,4-tetrahydroisoquinoline 
• 1443827-82-4 N-(3,4-dimethylphenethyl)-2-(4-methoxyphenoxy)acetamide 
• 1443828-34-9 (3-bromophenyl)(1-((4-methoxyphenoxy)methyl)-6,7-dimethyl-3,4-dihydroisoquinolin-2(1H)-yl)methanone 
• 1443828-33-8 (3-chlorophenyl)(1-((4-methoxyphenoxy)methyl)-6,7-dimethyl-3,4-dihydroisoquinolin-2(1H)-yl)methanone 
• 1443827-92-6 C₁₉H₂₁NO₂ 

Relevant academic research and scientific papers

Phenylacetamide derivatives and pharmaceutical compositions thereof

The present invention provides novel phenylacetamide derivatives having the following formula STR1 wherein: X is a hydrogen, halogen, hydroxy, nitro, amino, R1, NR1 R2, NHR1 or OR1 wherein R1/su

Novel phenylacetamide derivatives and processes for the preparation thereof

The present invention provides novel phenylacetamide derivatives having the following formula wherein:, X is a hydrogen, halogen, hydroxy, nitro, amino, R1, NR1R2, NHR1 or OR1 wherein R1 and R2 are an optionally substituted C1 8 alky

Process for the preparation of (8As,12AS,13AS)-decahydroisoquino ((2,1-G) (1,6)-naphthyridin-8-one derivatives

The invention provides a process for preparing single enantiomers of compounds represented by the formula: STR1 and chiral acid addition salts thereof; wherein: X and Y are independently hydrogen; lower alkyl; lower alkoxy; or halo; or X and Y taken together is methylenedioxy or ethylene-1,2-dioxy; which includes reduction of a compound represented by the formula: STR2 to give a mixture of stereoisomers represented by the formula: STR3 wherein each wavy line independently represents a bond in either the α or β position; followed by dissolving the mixture of stereoisomers and a chiral resolving acid in a suitable solvent and allowing the solution to crystallize, giving a salt of the desired enantiomer.